Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for Ventilator-Free Days in COVID-19
NCT04979221Phase 3Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jul 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyproheptadine in COVID-19 pneumonia, sponsored by Hospital de Clínicas de Porto Alegre. Status: unknown.
02
Drugs
cyproheptadine
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04979221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04979221.